Á lódáil...
Roxadustat and thyroid-stimulating hormone suppression
Hypoxia-inducible factor prolyl-hydroxylase inhibitors belong to a new class of orally administered drugs for treating anemia in patients with chronic kidney disease (CKD). The prevalence of hypothyroidism is disproportionately high in patients with CKD on hemodialysis. We report a rapid suppression...
Na minha lista:
| Foilsithe in: | Clin Kidney J |
|---|---|
| Main Authors: | , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Oxford University Press
2021
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087136/ https://ncbi.nlm.nih.gov/pubmed/33959275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfab007 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|